Literature DB >> 7996332

Treatment of compartmental liquefaction as a late sequelae of a lower limb compartment syndrome.

J S Early1, D S Ricketts, S T Hansen.   

Abstract

Symptomatic liquefaction and calcification of muscle tissue as a late sequela of compartment syndrome of the lower leg is rare. The literature shows a high complication rate involved with simple debridement of these compartments. In our limited experience, complete compartmental debridement and immediate introduction of functional viable muscle may prevent the documented complications of chronic drainage and infection.

Entities:  

Mesh:

Year:  1994        PMID: 7996332     DOI: 10.1097/00005131-199410000-00015

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  6 in total

1.  [Unclear soft-tissue tumor].

Authors:  J Hauser; D Drücke; M Lehnhardt; H U Steinau; H H Homann
Journal:  Chirurg       Date:  2007-01       Impact factor: 0.955

2.  Dermatomyositis and calcific myonecrosis in the leg: ultrasound as an aid in management.

Authors:  Richard Batz; Carolyn M Sofka; Ronald S Adler; Douglas N Mintz; Edward Dicarlo
Journal:  Skeletal Radiol       Date:  2005-10-05       Impact factor: 2.199

3.  Orthopaedic case of the month: Painful lower-leg mass in a 76-year-old man.

Authors:  Prasad J Sawardeker; Check C Kam; J David Pitcher; H Thomas Temple
Journal:  Clin Orthop Relat Res       Date:  2011-10       Impact factor: 4.176

4.  Calcific myonecrosis of the antetibial area.

Authors:  Young Soo Chun; Hee Seok Shim
Journal:  Clin Orthop Surg       Date:  2010-08-03

5.  Calcific myonecrosis: a report of ten new cases with an emphasis on MR imaging.

Authors:  M Dhillon; A M Davies; J Benham; N Evans; D C Mangham; R J Grimer
Journal:  Eur Radiol       Date:  2004-10-06       Impact factor: 5.315

6.  Calcific myonecrosis and the role of imaging in the diagnosis: a case report.

Authors:  Atsushi Okada; Masahito Hatori; Masami Hosaka; Munenori Watanuki; Eiji Itoi
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.